Showing 1 - 20 results of 39 for search '"stomach cancer"', query time: 0.07s Refine Results
  1. 1

    Biomarkers of gastric atrophy at stomach cancer by A. V. Belkovets, S. A. Kurilovich., Yu. I. Ragino, L. V. Scherbakova, O. B. Cheremisina, N. V. Cherdyntseva, N. A. Andryushina, M. I. Voyevoda

    Published 2018-08-01
    “…Atrophic gastritis (AG), being the basic premalignant condition for the stomach cancer (SC), is commonly diagnosed and screened for by noninvasive biomarkers (pepsinogens, gastrin-17), however the data on those biomarkers at SC is inconsistent. …”
    Get full text
    Article
  2. 2

    Stomach cancer risk factors: the modern concept by V. M. Khomyakov, A. D. Yermoshina, S. S. Pirogov, A. B. Ryabov

    Published 2018-08-01
    “…To present the systematic overview of the stomach cancer risk factors to determine prophylactic measures and to define high-risk groups of population that can be included to the screening programs. …”
    Get full text
    Article
  3. 3
  4. 4
  5. 5
  6. 6

    Stomach cancer epidemic in Chinese mainland: Current trends and future predictions by Wenxuan Zhu, Wanyue Dong, Yunning Liu, Ruhai Bai, Jinjiao Li

    Published 2025-01-01
    “…China is one of the countries with the highest burdens of stomach cancer. The objective of this study was to analyze long-term trends in the incidence and mortality of stomach cancer in Chinese mainland from 1990 to 2019 and to make projections until 2030. …”
    Get full text
    Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    Endoscopic Mucosal Resection for Esophageal and Gastric Mucosal Cancers by Haruhiro Inoue

    Published 1998-01-01
    “…In conclusion, EMR can be considered as the first-line treatment for selected cases of early stage esophageal and stomach cancer.…”
    Get full text
    Article
  17. 17

    Autoimmune gastritis pathogenesis and risk factors of stomach malignant neoplasia by Ye. A. Losik, V. T. Ivashkin

    Published 2015-09-01
    “…To demonstrate possible pathways of development of stomach malignant neoplasias at autoimmune gastritis.Key points. Stomach cancer traditionally occupies one of the first places within oncologic diseases in the world. …”
    Get full text
    Article
  18. 18

    Update on Helicobacter pylori infection study and key points of «Maastricht-V» consensus conference (2016) by A. A. Sheptulin, T. L. Lapina, V. O. Kaybysheva

    Published 2018-08-01
    “…The special attention was paid for decreasing of infection burden and the stomach cancer prevention. New eradication therapy modes were presented for the regions with high and low H. pylori resistance to clarithromycin and metronidazole. …”
    Get full text
    Article
  19. 19

    The role of endoscopic investigation in expertise and rehabilitation diagnostics of patients and disabled persons after stomach surgery by K. A. Velikolug, Zh. M. Sizova, Ye. K. Baranskaya

    Published 2012-02-01
    “…Overall 156 patients after stomach and duodenum surgery were investigated (99 had «peptic ulcer» diagnosis and 57 – diagnosis of «stomach cancer»). In resected stomach diseases physical disability was mainly caused by dumping syndrome. …”
    Get full text
    Article
  20. 20

    Results of long-term follow-up of patients with chronic gastritis after <i>H. pylori</i> eradication by T. L. Lapina, A. S. Tertychny, E. R. Nasretdinova, I. M. Kartavenko, A. V. Paraskevova, Ye. Yu. Yur’yeva, O. A. Storonova, A. S. Trukhmanov, V. T. Ivashkin

    Published 2015-09-01
    “…To analyze approach for long-term management of patients with chronic gastritis after H. pylori eradication for stomach cancer prevention by the example of clinical cases.Key points. …”
    Get full text
    Article